X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (323) 323
malaria (236) 236
female (185) 185
index medicus (181) 181
male (152) 152
antimalarials - adverse effects (147) 147
adult (123) 123
animals (115) 115
infectious diseases (77) 77
malaria - drug therapy (77) 77
antimalarials - therapeutic use (76) 76
middle aged (76) 76
malaria - prevention & control (64) 64
adolescent (63) 63
malaria, falciparum - drug therapy (63) 63
parasitology (61) 61
malaria - complications (60) 60
pregnancy (59) 59
child (58) 58
parasitic diseases (57) 57
antimalarials - administration & dosage (56) 56
health aspects (55) 55
research (52) 52
child, preschool (51) 51
plasmodium falciparum (50) 50
tropical medicine (50) 50
risk factors (46) 46
medicine, general & internal (45) 45
parasites (41) 41
artemisinins - adverse effects (40) 40
mice (40) 40
drug therapy (39) 39
anemia, hemolytic - chemically induced (38) 38
antimalarials (38) 38
chloroquine (37) 37
complications and side effects (37) 37
children (36) 36
drug combinations (36) 36
infant (36) 36
anemia (35) 35
chloroquine - adverse effects (35) 35
immunology (34) 34
quinine - adverse effects (34) 34
mefloquine - adverse effects (33) 33
pharmacology & pharmacy (33) 33
malaria, falciparum - complications (32) 32
infections (31) 31
plasmodium-falciparum (30) 30
vector-borne diseases (30) 30
young adult (30) 30
erythrocytes (29) 29
artesunate (28) 28
microbiology (28) 28
public, environmental & occupational health (28) 28
drugs (27) 27
plasmodium-falciparum malaria (27) 27
drug therapy, combination (26) 26
mortality (26) 26
research article (26) 26
artemisinins - administration & dosage (25) 25
artemisinins - therapeutic use (25) 25
mefloquine (25) 25
pyrimethamine - adverse effects (25) 25
care and treatment (24) 24
dosage and administration (24) 24
falciparum-malaria (24) 24
medicine (24) 24
treatment outcome (24) 24
prevention (22) 22
proteins (22) 22
studies (22) 22
toxicity (22) 22
vaccines (22) 22
infectious and parasitic diseases (21) 21
malaria - parasitology (21) 21
review (21) 21
tropical diseases (21) 21
analysis (20) 20
cerebral malaria (20) 20
infant, newborn (20) 20
arctic medicine. tropical medicine (19) 19
double-blind (19) 19
glucosephosphate dehydrogenase deficiency - complications (19) 19
malaria - epidemiology (19) 19
malaria, falciparum - parasitology (19) 19
plasmodium (19) 19
pyrimethamine - therapeutic use (19) 19
sulfadoxine - adverse effects (19) 19
time factors (19) 19
aged (18) 18
drug dosages (18) 18
infectious disease (18) 18
mefloquine - therapeutic use (18) 18
patients (18) 18
artemether-lumefantrine (17) 17
blood (17) 17
efficacy (17) 17
malaria vaccine (17) 17
medical research (17) 17
primaquine - adverse effects (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (362) 362
French (15) 15
Spanish (4) 4
German (3) 3
Chinese (1) 1
Dutch (1) 1
Hungarian (1) 1
Portuguese (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2018, Volume 2018, Issue 11, p. CD011444
Background The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine‐pyrimethamine for malaria for all... 
Pregnancy Complications | Stillbirth | Antimalarials | Pregnancy Complications, Infectious | Prevention | Infectious disease | Vomiting | Sulfadoxine | Drug Therapy, Combination | Parasitemia | HIV Seronegativity | Mefloquine | Malaria | Drugs for preventing malaria | Anemia | Pyrimethamine | Pregnancy & childbirth | Drugs for prevention for people living in endemic areas | Infection during pregnancy | Placenta Diseases | Malaria prevention & treatment | Randomized Controlled Trials as Topic | Trimethoprim, Sulfamethoxazole Drug Combination | Blood disorders | Medicine General & Introductory Medical Sciences | Drug Combinations | Abortion, Spontaneous [chemically induced; epidemiology] | HIV Infections [complications] | ANTIMALARIAL AGENTS | Africa South of the Sahara [epidemiology] | EFFICACY | LOW-BIRTH-WEIGHT | Humans | Trimethoprim | SULFADOXINE-PYRIMETHAMINE RESISTANCE | Thailand [epidemiology] | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | Insecticide-Treated Bednets | Parasitemia [epidemiology] | Combination | PLASMODIUM-FALCIPARUM | INFANTS | Female | INFECTION | Pregnancy Complications, Parasitic [epidemiology; prevention & control] | Infant, Low Birth Weight | Mefloquine [adverse effects; therapeutic use] | Drug Therapy | RISK | Antimalarials [adverse effects; therapeutic use] | Dizziness [chemically induced; epidemiology] | Sulfadoxine [adverse effects; therapeutic use] | Pregnancy | Malaria [epidemiology; prevention & control] | HIV | Vomiting [chemically induced; epidemiology] | Sulfamethoxazole Drug Combination [therapeutic use] | Pyrimethamine [adverse effects; therapeutic use] | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Placenta Diseases - epidemiology | Anemia - epidemiology | Pregnancy Complications, Infectious - epidemiology | Antimalarials - therapeutic use | Parasitemia - drug therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Placenta Diseases - parasitology | Mefloquine - adverse effects | Malaria - prevention & control | Vomiting - chemically induced | Mefloquine - therapeutic use | Sulfadoxine - therapeutic use | Pregnancy Complications, Infectious - prevention & control | Pregnancy Complications - chemically induced
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 02/2016, Volume 2016, Issue 2, p. CD006589
Background Iron‐deficiency anaemia is common during childhood. Iron administration has been claimed to increase the risk of malaria. Objectives To evaluate the... 
Folic Acid | Anemia, Iron‐Deficiency | Malaria | Malaria: treating fever & anaemia | Antimalarials | Iron | Randomized Controlled Trials as Topic | Endemic Diseases | Infectious disease | Blood disorders | Treatment | Child health | Symptomatic treatment | Treating fever & anaemia | Malaria: other treatments | Parasitemia | Medicine General & Introductory Medical Sciences | Dietary Supplements | Dietary Supplements [adverse effects] | Humans | CELL-MEDIATED-IMMUNITY | Preschool | Parasitemia [chemically induced; complications] | RANDOMIZED CONTROLLED-TRIAL | ZINC SUPPLEMENTATION | Folic Acid [adverse effects] | FOLIC-ACID | VITAMIN-A | DEFICIENCY ANEMIA | MEDICINE, GENERAL & INTERNAL | WEEKLY MICRONUTRIENT SUPPLEMENTATION | INTERMITTENT PREVENTIVE TREATMENT | Malaria [chemically induced; complications] | Adolescent | Anemia, Iron-Deficiency [etiology; prevention & control] Antimalarials [administration & dosage] | Iron [administration & dosage; adverse effects] | PLACEBO-CONTROLLED TRIAL | Child | ROUTINE PROPHYLACTIC SUPPLEMENTATION | Iron - administration & dosage | Folic Acid - adverse effects | Anemia, Iron-Deficiency - etiology | Parasitemia - complications | Child, Preschool | Anemia, Iron-Deficiency - prevention & control | Iron - adverse effects | Malaria - chemically induced | Parasitemia - chemically induced | Antimalarials - administration & dosage | Malaria - complications | Dietary Supplements - adverse effects
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 03/2018, Volume 2018, Issue 3, p. CD011444
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9563, pp. 757 - 765
Summary Background The burden of Plasmodium vivax infections has been underappreciated, especially in southeast Asia where chloroquine resistant strains have... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | PHARMACOKINETICS | EFFICACY | DIHYDROARTEMISININ-PIPERAQUINE | SULFADOXINE-PYRIMETHAMINE | ARTEMETHER-LUMEFANTRINE | MEFLOQUINE | CHLOROQUINE | UNCOMPLICATED PLASMODIUM-FALCIPARUM | FAILURE | CHILDREN | Recurrence | Prospective Studies | Drug Resistance, Multiple - drug effects | Humans | Middle Aged | Fluorenes - therapeutic use | Child, Preschool | Infant | Male | Sesquiterpenes - administration & dosage | Diarrhea - chemically induced | Quinolines - administration & dosage | Sesquiterpenes - adverse effects | Malaria, Vivax - complications | Adult | Female | Child | Anemia - etiology | Antimalarials - adverse effects | Malaria, Falciparum - drug therapy | Drug Administration Schedule | Artemisinins - administration & dosage | Treatment Outcome | Malaria, Falciparum - complications | Vomiting - chemically induced | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Malaria, Vivax - drug therapy | Adolescent | Urticaria - chemically induced | Ethanolamines - therapeutic use | Artemisinins - adverse effects | Drug Combinations | Quinolines - adverse effects | Indonesia | Usage | Care and treatment | Malaria | Drug resistance | Health aspects | Artemisia | Medical research | Ethics | Comparative studies | Risk | Infections | Drug therapy | Patients | Children & youth | Dihydroartemisinin | Vector-borne diseases | Clinics | Chloroquine | Prophylaxis | Artemisinin | Studies | Motivation | Failure analysis | Artemether | Gametocytes | Index Medicus | Abridged Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 2017, Volume 12, Issue 2, p. e0168780
Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy or as fixed combination with sulfadoxine-pyrimethamine... 
RESISTANT FALCIPARUM-MALARIA | CLINICAL-TRIAL | PHARMACOKINETICS | PLASMODIUM-FALCIPARUM | ARTEMETHER-LUMEFANTRINE | DIHYDROARTEMISININ-PIPERAQUINE | MULTIDISCIPLINARY SCIENCES | ARTESUNATE-MEFLOQUINE | DOUBLE-BLIND | RANDOMIZED-TRIAL | COMBINATION | Outcome Assessment (Health Care) - methods | Nausea - chemically induced | Humans | Child, Preschool | Male | Sulfadoxine - adverse effects | Plasmodium falciparum - drug effects | Thailand | Dose-Response Relationship, Drug | Young Adult | Mefloquine - therapeutic use | Sulfadoxine - therapeutic use | Artesunate | Adult | Female | Plasmodium falciparum - physiology | Drug Therapy, Combination | Child | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Plasmodium vivax - drug effects | Pyrimethamine - adverse effects | Dizziness - chemically induced | Antimalarials - therapeutic use | Mefloquine - adverse effects | Host-Parasite Interactions - drug effects | Plasmodium vivax - physiology | Vomiting - chemically induced | Artemisinins - therapeutic use | Outcome Assessment (Health Care) - statistics & numerical data | Adolescent | Malaria - parasitology | Anorexia - chemically induced | Malaria - drug therapy | Artemisinins - adverse effects | Drug Combinations | Psychotic Disorders - etiology | Drugs | Complications and side effects | Mefloquine | Malaria | Adverse and side effects | Dosage and administration | Drug therapy | Risk factors | Vector-borne diseases | Multidrug resistance | Erythrocytes | Pyrimethamine | Clinical trials | Parasites | Drug resistance | Dosage | Patients | Medicine | Confidence intervals | Studies | Side effects | Vomiting | Antimalarial agents | New combinations | Sulfadoxine | Drug dosages
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 2, p. e87743
Journal Article
Travel Medicine and Infectious Disease, ISSN 1477-8939, 2014, Volume 13, Issue 1, pp. 80 - 88
Summary Background The aim of the study was to explore the profile of acute and long-term psychiatric side effects associated with mefloquine. Methods Subjects... 
Infectious Disease | Mania | Bipolar | Depression | Anxiety | Psychotic | POPULATION | INFECTIOUS DISEASES | FALCIPARUM-MALARIA | GENETIC LIABILITY | PYRIMETHAMINE | MAJOR DEPRESSION | MALARIA CHEMOPROPHYLAXIS | SF-36 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | DOUBLE-BLIND | HEALTH | LIFE EVENTS | Bipolar Disorder - chemically induced | Follow-Up Studies | Humans | Middle Aged | Male | Hallucinations - epidemiology | Young Adult | Time Factors | Depression - chemically induced | Anxiety - epidemiology | Adult | Female | Surveys and Questionnaires | Antimalarials - adverse effects | Acute Disease | Depression - epidemiology | Mental Disorders - epidemiology | Mental Disorders - chemically induced | Adverse Drug Reaction Reporting Systems | Hallucinations - chemically induced | Mefloquine - adverse effects | Psychoses, Substance-Induced - epidemiology | Psychoses, Substance-Induced - etiology | Denmark - epidemiology | Aged | Anxiety - chemically induced | Electronic Health Records | Bipolar Disorder - epidemiology | Schizophrenia | Complications and side effects | Analysis | Psychiatric services | Studies | Ethics | Mental health care | Illnesses | Mental disorders | Questionnaires | Population | Gender | Interviews | Age | Infectious Medicine | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Infektionsmedicin
Journal Article
eLife, ISSN 2050-084X, 02/2017, Volume 6
.... A compartmental model of the dynamics of red blood cell production and destruction was designed to characterise primaquine-induced haemolysis using a holistic Bayesian analysis of all published data... 
RELAPSE | MALARIA | ANEMIA | ERYTHROCYTES | PLASMODIUM-VIVAX | BIOLOGY | Hemolysis - drug effects | Plasmodium vivax - growth & development | Recurrence | Humans | Male | Anemia, Hemolytic - prevention & control | Primaquine - administration & dosage | Malaria, Vivax - complications | Female | Cell Death - drug effects | Malaria, Vivax - pathology | Antimalarials - adverse effects | Glucosephosphate Dehydrogenase Deficiency - parasitology | Plasmodium vivax - drug effects | Malaria, Vivax - parasitology | Glucosephosphate Dehydrogenase Deficiency - pathology | Models, Statistical | Erythrocytes - drug effects | Glucosephosphate Dehydrogenase Deficiency - complications | Glucosephosphate Dehydrogenase Deficiency - drug therapy | Antimalarials - administration & dosage | Malaria, Vivax - drug therapy | Bayes Theorem | Anemia, Hemolytic - diagnosis | Anemia, Hemolytic - chemically induced | Primaquine - adverse effects | Dosage and administration | Observations | Primaquine | Drug interactions | Hemolysis and hemolysins | Enzymes | Malaria | Infections | Males | Patients | Blood | Medicine | Glucose dehydrogenase | Bone marrow | Population | Production capacity | Glucosephosphate dehydrogenase | Bayesian analysis | Drug dosages | Hemolysis | Malaria, Vivax | Erythrocytes | Antimalarials | Anemia, Hemolytic | Life Sciences | Plasmodium vivax | Human health and pathology | Infectious diseases | Cell Death | Glucosephosphate Dehydrogenase Deficiency
Journal Article